| pubmed-article:15289793 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0376387 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0018823 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0965129 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0332257 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:15289793 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
| pubmed-article:15289793 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15289793 | pubmed:dateCreated | 2004-8-3 | lld:pubmed |
| pubmed-article:15289793 | pubmed:abstractText | Cyclosporine (INN, ciclosporin) increases the systemic exposure of all statins. Therefore rosuvastatin pharmacokinetic parameters were assessed in an open-label trial involving stable heart transplant recipients (> or =6 months after transplant) on an antirejection regimen including cyclosporine. Rosuvastatin has been shown to be a substrate for the human liver transporter organic anion transporting polypeptide C (OATP-C). Inhibition of this transporter could increase plasma concentrations of rosuvastatin. Therefore the effect of cyclosporine on rosuvastatin uptake by cells expressing OATP-C was also examined. | lld:pubmed |
| pubmed-article:15289793 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15289793 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15289793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289793 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15289793 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15289793 | pubmed:issn | 0009-9236 | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:RazaAliA | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:MartinPaul... | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:JarchoJohn... | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:SchneckDennis... | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:MitchellPatri... | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:SimonsonSteve... | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:BrownColin... | lld:pubmed |
| pubmed-article:15289793 | pubmed:author | pubmed-author:WindassAmy... | lld:pubmed |
| pubmed-article:15289793 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15289793 | pubmed:volume | 76 | lld:pubmed |
| pubmed-article:15289793 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15289793 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15289793 | pubmed:pagination | 167-77 | lld:pubmed |
| pubmed-article:15289793 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:meshHeading | pubmed-meshheading:15289793... | lld:pubmed |
| pubmed-article:15289793 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15289793 | pubmed:articleTitle | Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. | lld:pubmed |
| pubmed-article:15289793 | pubmed:affiliation | AstraZeneca, Wilmington, Del, USA. steven.simonson@astrazeneca.com | lld:pubmed |
| pubmed-article:15289793 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15289793 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15289793 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15289793 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289793 | lld:pubmed |
